Chartreusin (Fig. 1) is an antimicrobial antibiotic that was first described by Leach et al. in 1953 (3) . Recently, chartreusin was shown to inhibit experimental tumors in animals (4) . Such results generated renewed interest in this drug.
Much of the fermentation technology has changed during the 23 years since the drug was first discovered. Accordingly, a considerable amount of work was done recently both on the fernentation and in the development of a suitable microbiological assay. The pertinent results are reported herein.
MATERIALS AND METHODS
Fermentation. The inocula of Streptomyces chartreusis NRRL-2287 were frozen plugs made from a petri plate heavy surface growth on agar and kept in a liquid nitrogen storage tank. The frozen plugs were used to inoculate the medium, which consisted of (grams per liter): cerelose, 10; corn steep liquor (Corn Products Co., Englewood Cliffs, N.J.), 10; Pharmamedia (Traders Oil Mill Co., Fort Worth, Tex.), 2; and liquid peptone (Wilson Protein Technology, Calumet City, I1.), 10. The cultivation was done for 48 h in 500-ml nonstippled flasks (each containing 100 ml of medium) on a rotary shaker (250 rpm) at 28°C. This inoculum was used to seed the production medium at the rate of 5% (vol/vol). The production medium was a slightly modified medium described previously by Calhoun and Johnson (1); it contained (grams per liter): lactose, 20; starch, 15; soybean meal (Lauhoff Grain Co., Danville, Ill.), 15; distillers solubles (Brown and Forman, Louisville, Ky.), 20; corn steep liquor, 5; NaCl, 5; CaCO3, 8; and lard oil, 10 ml/liter. The fermentation was carried out in nonstippled flasks at 28°C.
Since the chartreusin molecule contains two monosaccharides, D-fucose and -digitalose, it appeared reasonable to examine the effect of incorporating these compounds into the fermentation media on the titer of the drug. Since D-digitalose was not readily available, only D-fucose was evaluated in these studies. It was used at three levels (20, 30, and 40 g/liter) to replace lactose in the production medium.
Microbiological assay. Since no practical microbiological assay was available, a large number of microorganisms were tested for susceptibility to chartreusin. The most susceptible organism appeared to be a strain of Sarcina lutea, UC-3383. A number of techniques were investigated before a satisfactory assay was developed. (The drug is poorly soluble in water; it is unstable in solution under some conditions; and it is apparently bound to the paper disks commonly used in microbiological assay.) The drug is first dissolved in 0.01 N NaOH to a concentration of 1 mg/ml. It is then further diluted in 0.1 M, pH 7.0 phosphate buffer to obtain concentrations of 10.0, 5, 2.5, 1.25, and 0.62 ,ug/ml, which are used for the construction of the standard curve. These solutions are kept frozen in the dark and are prepared fresh every week.
The microorganism used for assay was cultivated in a synthetic medium of the following composition: Na1HPO4 * 7H10, 2 g; KH2PO4, 0.5 g; (NH4)2SO4, 1 g; MgSO4, 0.1 g; glucose, 2 g; distilled water, 1 liter. After autoclaving, this medium was further supplemented aseptically with sterile solutions of: glycine, 20 mg; valine, 20 mg; isoleucine, 20 mg; glutamine, 20 mg; cysteine, 20 mg; adenosine, 20 mg; metallic ion stock solution (1), 1 ml; vitamin mixture (Eagle, 100 x; Microbiological Associates, Bethesda, Md.), 1 ml. This medium was inoculated with S. lutea and cultivated in Erlenmeyer flasks for 16 h on a reciprocating shaker at 32°C. This culture was used to inoculate (at a rate of 0.2 ml/100 ml) the assay agar of the following composition: Na2HPO4-7H20, 3 g; KH2PO4, 0.2 g; nutrient broth (Difco), 4 g; glucose, 1 g; agar, 15 g; distilled water, 1 liter. The inoculated agar was dispensed into plastic petri This is necessary because a substantial percentage (-50%) of the drug is "locked" in the mycelium. The samples of the diluted fermentation liquors and the standard solutions were applied in penicylinders, using volumes of 0.3 ml/cup. The plates were then incubated at 32°C for 16 to 20 h. After incubation, the zones of inhibition were recorded, and the potency of the unknown samples was estimated from the standard curve.
RESULTS AND DISCUSSION Fermentation. The results of a typical fermentation run are presented in Table 1 . High titers of 200 to 300 ,ug/ml were obtained repeatedly in both 500-ml fermentation flasks and small (250-liter) tanks.
The effect of substituting fucose for lactose (Table 2 ) was very pronounced. The medium containing 40 g of fucose per liter produced an excellent titer of 1,162 ,ug of chartreusin per ml after 4 days of fermentation, which was three times higher than medium with lactose.
Microbiological assay. A typical dose response of chartreusin on S. lutea is presented in Fig. 2 . In assays of clinical samples where higher sensitivity is required, it was possible to double the sensitivity of the assay by refrigerating the spotted plates for 3 to 4 h before incubation. In samples of too low potency, it was possible to extract the drug with chloroform before assay and reconstitute in smaller volumes to reach detectable concentrations.
